Screener
Collegium Pharmaceutical, Inc. COLL Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$15.05M-226% | $14.5M+500% | $16.96M+35.3% | $31.51M+238% | $11.98M-38.9% | ||
| $1.81M+59.6% | $463K-57.6% | $923K-11.3% | $1.03M+9.2% | $1.14M+19.2% | ||
| $14.48M+33.9% | $10.88M-5.6% | $9.75M+28.4% | $9.81M+34.1% | $10.82M+8.1% | ||
| $71.32M-1.5% | $57.11M+3.1% | $123.05M+45.4% | $78.44M— | $72.44M+7.5% | ||
| $496K+663% | $270K-66.2% | $689K+20.9% | $188K-23.0% | $65K-75.9% | ||
| —— | —— | $0-100% | $0-100% | $0-100% | ||
| -$502.59M-17,142% | $1.63M+117% | -$20.07M-70.6% | -$30.87M+87.6% | -$2.92M+67.3% | ||
| $0-100% | —— | —— | —— | $25.1M— | ||
| $7.25M-55.1% | $7.25M-55.1% | $587.12M+3,536% | $16.15M— | $16.15M-64.8% | ||
| $292.09M+704% | -$21.34M+15.4% | -$21.82M+47.1% | -$14.82M— | -$48.37M+57.6% | ||
| -$139.18M-758% | $37.4M+82.6% | $81.16M— | $32.75M+130% | $21.15M+138% | ||
| $70.83M-2.1% | $56.84M+4.1% | $122.36M+45.5% | $78.25M— | $72.37M+7.8% |
FAQ
- How much cash does Collegium Pharmaceutical, Inc. generate?
- Collegium Pharmaceutical, Inc. (COLL) generated $329.9M in operating cash flow over the trailing twelve months.
- What is Collegium Pharmaceutical, Inc.'s free cash flow?
- After $1.6M of capital expenditures, Collegium Pharmaceutical, Inc.'s free cash flow was $328.3M over the trailing twelve months, up 55.5% year over year.
- Where does Collegium Pharmaceutical, Inc.'s cash flow data come from?
- Every line is extracted from Collegium Pharmaceutical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
